Understanding COVID-19 is the key to fighting it
La Jolla Institute for Immunology, one of the leading global organizations dedicated to studying the immune system, has stepped up to provide much needed information and real solutions for the COVID-19 outbreak and to improve how we respond to future emerging infectious diseases. We have launched a multi-lab Coronavirus Taskforce that capitalizes on our competitive advantages of unique skill in infectious disease research, state-of-the-art technology, and being a highly collaborative organization. And we also remain committed to educating the public about immunology research, especially during the COVID-19 pandemic.
While the global COVID-19 vaccination campaign continues, there are many questions circulating about the mRNA and Johnson & Johnson/Janssen COVID-19 vaccines approved for use in the U.S. and we have the science-based, data-driven answers. This brief, easy-to-understand e-guide updated in April 2020 (after being initially developed in February 2021) will keep you informed and empower you to engage in conversations about the safety and efficacy of these vaccines and the groundbreaking research underway related to fighting COVID-19. Stay informed and lead conversations using this the COVID-19 Vaccines Resource Guide.